(thirdQuint)Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068).

 In stage I, VAQTA cent given concomitantly with Infanrix cent and/or PedvaxHIB cent was evaluated.

 In stage 2: Two (2) doses of the VAQTA cent vaccine were administered at least 6 months apart.

 Safety data was collected after each dose.

.

 Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)@highlight

This two-stage study evaluates the immunogenicity, safety, and tolerability of the administration of VAQTA cent (Hepatitis A Vaccine, Inactivated) concomitantly with PedvaxHIB cent (Haemophilus B Conjugate Vaccine [Meningococcal Protein Conjugate]) and Infanrix cent (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, GlaxoSmithKline) versus the administration of VAQTA cent in healthy children 15 months of age at study entry.

